| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1150999B1 Cyclosporin derivatives and method for the production of said derivatives |
| 06/21/2006 | CN1789279A Inhibitory peptide of YMDD domain of duck hepatitis-B virus polymerase protein and application thereof |
| 06/21/2006 | CN1260250C Preparation method of thymopentapeptide |
| 06/20/2006 | US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases |
| 06/20/2006 | US7064105 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 06/20/2006 | US7063949 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 06/20/2006 | US7063847 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/20/2006 | US7063842 Compounds and methods for inhibiting the interaction between α-catenin and β-catenin |
| 06/15/2006 | WO2006062173A1 Bcl-xL HETERODIMER INHIBITORY PEPTIDE ENHANCING THE EFFECT OF ANTICANCER AGENT AND METHOD OF SCREENING THE SAME |
| 06/15/2006 | WO2006060903A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | WO2005119230A3 Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics |
| 06/15/2006 | WO2005007683A8 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use |
| 06/15/2006 | US20060130158 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 06/15/2006 | US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity |
| 06/15/2006 | US20060128631 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128628 Human tissue antigen-binding peptides and their amino acid sequences |
| 06/15/2006 | US20060128626 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 06/15/2006 | US20060128618 Peptide binds erythropoietin receptors; for treatment of anemia and stroke |
| 06/15/2006 | US20060128614 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 06/15/2006 | US20060128613 Melanocortin receptor ligands |
| 06/15/2006 | US20060128609 N¹- modified glycopeptides |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | CA2630088A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | CA2593034A1 Compositions and methods based upon the kinase haspin |
| 06/14/2006 | EP1669453A1 Novel nerve stem cell marker |
| 06/14/2006 | EP1669367A1 Peptides which can bind to transforming growth factor beta 1 (tgf-beta1) |
| 06/14/2006 | EP1668067A2 Crosslinking within coordination complexes |
| 06/14/2006 | EP1668027A2 Cyclic peptides acting as urotensin-ii antagonists |
| 06/14/2006 | EP1667998A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/14/2006 | EP1667707A1 Methods of stimulating innate immunity using cationic peptides |
| 06/14/2006 | EP1667702A2 Peptides that inhibit complement activation |
| 06/14/2006 | EP1667700A2 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 06/14/2006 | EP1379650B1 Preferred segments of neural thread protein and methods of using the same |
| 06/14/2006 | EP1341819B1 Use of fibrin/fibrinogen peptides and proteins for the manufacture of a medicament |
| 06/14/2006 | EP1102596B1 Peptide antagonists of zonulin and methods for use of the same |
| 06/14/2006 | EP1045926B1 Gene family with transformation modulating activity |
| 06/14/2006 | CN1786021A 12 amino acid analog epi-position of human B cell specificity membrane molecule CD20 and polypeptide epi-position vaccine configurated by said analog epi-position |
| 06/14/2006 | CN1786020A Inhibition peptide of hepatatitis B virus polyzymoprotein YMDD functional region and its application |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/13/2006 | US7060719 Glutaminyl based DPIV inhibitors |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/13/2006 | US7060679 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 06/13/2006 | US7060678 peptidomimetic analogs of VIP receptor binding inhibitors replacing the di-/tri-peptides having proline as one of the amino acids, or proline alone, with at leat one unit from enantiomorphic 4-(aminomethyl)tetrahydrofuran-2-carboxylic acid |
| 06/13/2006 | US7060673 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same |
| 06/13/2006 | US7060671 Peptides containing N-substituted D-amino acids for preventing β-strand association |
| 06/13/2006 | US7060669 in aqueous two-phase systems by fusing hydrophobin or hydrophobin-like protein to a protein of interest, such as an extracellular protein of Trichoderma, selected from the group consisting of cellulases, hemicellulases and proteases. |
| 06/13/2006 | US7060284 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 06/13/2006 | US7060266 Human brain carboxypeptidase B |
| 06/13/2006 | US7060247 Metal complexed with chelating group attached to gastrin releasing peptide receptor agonist which includes a bombesin agonist binding moiety; for use as therapeutic or diagnostic radiopharmaceutical |
| 06/08/2006 | WO2006060643A2 Novel bladder matrix protein peptides and methods of detection of bladder cancer |
| 06/08/2006 | WO2006059914A1 Modulation of ovulation |
| 06/08/2006 | WO2006059913A1 Modulation of ovulation |
| 06/08/2006 | WO2006058496A1 Mimic antigen epitope of her-2 and composition which comprise such epitope |
| 06/08/2006 | WO2006058436A1 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 06/08/2006 | WO2006032923A3 Inhibitors of protein kinase a anchoring |
| 06/08/2006 | WO2006004620A3 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/08/2006 | WO2005115097A3 Cyclic peptide antibiotics |
| 06/08/2006 | WO2005000878A8 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 06/08/2006 | US20060122371 Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same |
| 06/08/2006 | US20060122370 Specific binding agents of human angiopoietin-2 |
| 06/08/2006 | US20060122368 Antigen delivery platform |
| 06/08/2006 | US20060122121 Modified alpha-MSH peptides and derivatives thereof |
| 06/08/2006 | US20060122120 Method of reducing the effects of Abeta and compositions therefore |
| 06/08/2006 | US20060122108 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 06/08/2006 | US20060122107 Method of modulating cellular activity and molecules for use therein |
| 06/08/2006 | US20060121553 Fluorogenic enzyme assay methods, kits and compositions using charge-balancers |
| 06/08/2006 | US20060121546 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 06/08/2006 | US20060121537 Cellular immunity test with peptides fixed on a solid support |
| 06/08/2006 | US20060121480 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/08/2006 | CA2590419A1 Modulation of ovulation |
| 06/08/2006 | CA2589898A1 Modulation of ovulation |
| 06/08/2006 | CA2589833A1 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 06/08/2006 | CA2588980A1 Vasopressin-binding l-nucleic acid |
| 06/07/2006 | EP1666587A1 Cyclic lipopeptide acylase |
| 06/07/2006 | EP1664332A2 Kinase and phosphatase assays |
| 06/07/2006 | EP1664095A2 Antimicrobial polypeptides |
| 06/07/2006 | EP1664093A1 New antitumoral compounds |
| 06/07/2006 | EP1664091A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/07/2006 | EP1664090A2 Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus |
| 06/07/2006 | EP1664080A2 Peptide-based diblock and triblock dispersants and diblock polymers |
| 06/07/2006 | EP1663276A2 Compounds that modulate neuronal growth and their uses |
| 06/07/2006 | EP1663275A2 Stationary phases and a purification process using the stationary phases |
| 06/07/2006 | EP1663118A2 Peptide-based conditioners and colorants for hair, skin, and nails |
| 06/07/2006 | EP1542730B1 Modified therapeutic agents |
| 06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
| 06/07/2006 | EP1315738A4 Extended native chemical ligation |
| 06/07/2006 | EP1165112B1 Modulators of polysaccharides and uses thereof |
| 06/07/2006 | EP1147127B1 Volatilizable solid phase supports for compound synthesis |
| 06/07/2006 | CN1784423A Peptides for use in treating obesity |
| 06/07/2006 | CN1784244A Prodrugs cleavable by CD26 |
| 06/07/2006 | CN1784239A Protease inhibitors for coronaviruses and SARS-COV and the use thereof |
| 06/07/2006 | CN1781939A Amidated horseshoe crab anti-endotoxin factor circular analogue peptide molecule, its synthetic method and use |
| 06/07/2006 | CN1781938A Method for preparing echinocandin derivatives |
| 06/07/2006 | CN1781937A Amidated horseshoe crab anti endotoxin factor linear analogue peptide molecule, its synthetic method and use |
| 06/07/2006 | CN1781936A B lymphocyte stimulus factor inhibiting peptide and its screening and preparing method |
| 06/07/2006 | CN1781935A Novel LHRH antagonist |
| 06/07/2006 | CN1781934A HER-2 analogue antigen epitope and peptide containing said epitope |
| 06/07/2006 | CN1781933A Thymosin alpha 1 active segment cyclicpeptide analogue and its poly glycol derivative |